Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI

Vaccine

Volumn 32, Issue 51, 2014, Pages 6956-6962

  Brewer, Kimberly D ^a,b   Lake, Kerry ^c   Pelot, Nicole ^c   Stanford, Marianne M ^a,b   DeBay, Drew R ^c   Penwell, Andrea ^a   Weir, Genevieve M ^a,b   Karkada, Mohan ^a,b   Mansour, Marc ^a   Bowen, Chris V ^b,c  

^a Immunovaccine Inc   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Biomedical Translational Imaging Centre (BIOTIC)   (Canada)

Author keywords

Cancer; HPV 16; MRI; Superparamagnetic iron oxide (SPIO); Vaccines

Indexed keywords

ANTIGEN; GAMMA INTERFERON; OIL; SUPERPARAMAGNETIC IRON OXIDE; VACCINE; DELAYED RELEASE FORMULATION; FERRIC ION; FERRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VIVO STUDY; INGUINAL LYMPH NODE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; VACCINATION; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; DELAYED RELEASE FORMULATION; HUMAN; PHARMACOKINETICS;

ANIMALS; DELAYED-ACTION PREPARATIONS; FEMALE; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE, INBRED C57BL; VACCINES;

EID: 84924039776     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.10.058     Document Type: Article

References (24)

1. Morse M.A., Whelan M. A year of successful cancer vaccines points to a path forward. Curr Opin Mol Ther 2010, 12:11-13.
2. Aly H.A.A. Cancer therapy and vaccination. J Immunol Methods 2012, 382:1-23.
3. Slingluff C.L. The present and future of peptide vaccines for cancer: single. or multiple, long or short, alone or in combination?. Cancer J 2011, 17:343-350.
4. Karkada M., Weir G.M., Quinton T., Sammatur L., MacDonald L.D., Grant A., et al. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses. J Immunother 2010, 33:250-261.
5. Dupuis M., McDonald D.M., Ott G. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine 2000, 18:434-439.
6. Calabro S., Tortoli M., Baudner B., Pacitto A., Cortese M., O'Hagan D.T., et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 2011, 29:1812-1823.
7. Christensen D., Henriksen-Lacey M., Kamath A.T., Lindenstrom T., Korsholm K., Christensen I.P., et al. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Controlled Release 2012, 160:468-476.
8. Da Costa Martins R., Gamazo C., Sanchez-Martinez M., Barberan M., Penuelas I., Irache J.M. Conjuctival vaccination against Brucella ovis in mice with mannosylated nanoparticles. J Controlled Release 2012, 162:533-560.
9. Debay D, LeBlanc SA, Weir GM, Mansour M, Bowen CV, MR visualization of depot vaccines and immune activation for cancer therapies. Proceedings of the 19th Annual ISMRM, Abstract #977.
10. Karkada M., Weir G.W., Quinton T., Fuentes-Ortega A., Mansour M. A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery. Vaccine 2010, 28:6176-6182.
11. Daftarian P.M., Mansour M., Pohajdak B., Fuentes-Ortega A., Korets-Smith E., Macdonald L., et al. Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides. J Transl Med 2007, 5:26-34.
12. Mansour M., Pohajdak B., Kast W.M., Fuentes-Ortega A., Korets-Smith E., Weir G.M., et al. Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax. J Transl Med 2007, 5:20-27.
13. Daftarian P., Mansour M., Benoit A.C., Pohajdak B., Hoskin D.W., Brown R.G., et al. Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion. Vaccine 2006, 24:5235-5244.
14. Berinstein N.L., Karkada M., Morse M.A., Nemunaitis J.J., Chatta G., Kaufman H., et al. First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J Transl Med 2012, 10:156-167.
15. Hailemichael Y., Dai Z., Jaffarzad N., Ye Y., Medina M.A., Huang X.-F., et al. Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nature Med 2013, 19:465-471.
16. Feltkamp M.C., Smits H.L., Vierboom M.P., Minnaar R.P., de Jongh B.M., Drijfhout J.W., et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993, 23:2242-2249.
17. "Magnetic nanoparticle coupling kit instructions", Ocean Nanotech product #ICK, Version # 20090301, Accessed 110212, Retrieved from. http://www.oceannanotech.com/upload/090616150107805814hag4ge.pdf.
18. Studholme C, Rview software, Version #9.043B, Retrieved from. http://rview.colin-studholme.net/.
19. Studholme C., Hill D.L.G., Hawkes D.J. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognit 1999, 32:71-86.
20. Haacke E.M., Brown R.W., Thompson M.R., Venkatesan R. Magnetic resonance imaging: physical principles and sequence design 1999, John Wiley and Sons, New York, USA.
21. Bowen C.V., Zhang X., Saab G., Gareau P.J., Rutt B.K. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002, 48:52-61.
22. Johnson L., Pinder S.E., Douek M. Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection. Histopathology 2013, 62:481-486.
23. Yang C.-Y., Tai M.-F., Lin C.-P., Lu C.-W., Wang J.-L., Hsiao J.-K., et al. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS One 2011, 6:e25524.
24. Baumjohann D., Hess A., Budinsky L., Brune K., Schuler G., Lutz M.B. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol 2006, 36:2544-2555.